APEX Ventures

Quibim, headquartered in Valencia, Spain, is a leader in whole-body medical imaging analysis, focusing on the integration of artificial intelligence in image processing. The company provides advanced solutions for extracting quantitative information from radiological images, which aids in the diagnosis of high-incidence illnesses and evaluates the effects of pharmacological treatments. Quibim Precision®, its comprehensive imaging ecosystem, is utilized by pharmaceutical companies and research teams worldwide for a variety of applications, including disease detection and monitoring treatment efficacy. By leveraging AI technology, Quibim enhances the ability to detect pathologies across all body parts and imaging modalities, ultimately contributing to improved health outcomes.

Robeaute is a research and development agency that develops neurosurgical microrobots that can adapt to different types of medical evidence.

HyperHeat is developing an innovative all-electric heating solution capable of achieving temperatures up to 2,000°C, providing a sustainable alternative to traditional fossil fuel combustion. By utilizing renewable electricity, HyperHeat offers a highly efficient system with an efficiency rate of up to 98%, making it particularly suitable for retrofitting industrial processes. This technology aims to significantly reduce CO2 emissions in energy-intensive industries such as steel, cement, and chemicals. As the company operates in stealth mode, it focuses on creating scalable and cost-effective solutions to decarbonize thermal processes, with the potential to contribute to a reduction of over 4.5 gigatons of global CO2 emissions annually.

GEMESYS, a German tech company, specializes in developing advanced AI chips. Founded as a spin-off from Ruhr-University Bochum, the company leverages memristors, novel electronic components, to create highly efficient neural network processing systems. Their technology enables on-device AI training and inference, opening up new possibilities for Edge AI applications.

TriLite Technologies GmbH, based in Vienna, Austria, specializes in manufacturing and selling ultra-small RGB laser beam scanners. These innovative products are designed for use in Augmented Reality (AR), Mixed Reality (MR), and Virtual Reality (VR) head-mounted devices, head-up displays, pico projectors, and smart home applications. TriLite's solutions leverage advanced machine learning algorithms and proprietary software, enabling the creation of compact, high-quality projection displays. The company's software-first approach ensures optimal image quality and user experience for its Original Equipment Manufacturer (OEM) customers.

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

Senisca is a senotherapeutics company established in 2020, focused on developing anti-aging oligonucleotide therapeutics. The company aims to provide innovative pharmaceutical treatments for age-related chronic diseases by creating a new generation of oligonucleotide-based interventions. These therapeutics target the underlying mechanisms of aging, restoring the ability of cells to regulate gene expression effectively. By rejuvenating aged cells, Senisca seeks to improve healthspan and address both the diseases and aesthetic manifestations of aging, ultimately enabling individuals to live healthier for longer periods.

Zetta Genomics is a company based in Cambridge, England, founded in 2018, that focuses on managing large-scale genomic data for precision medicine. It operates a user-centric platform that facilitates direct connections between individuals and researchers, allowing users to share their personal health and genomic data. This platform supports research into a range of common disorders, such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. Zetta Genomics enables individuals to participate in studies with the choice to opt in or out, ensuring they have transparency and control over their data. The company utilizes distributed database technology and adheres to strict security practices to maximize the benefits of genomic data while maintaining data privacy.

Solvemed Limited stands at the forefront of innovation in neurological care, leveraging advanced AI technology to pioneer precision diagnostics and personalized treatment recommendations. Our cutting-edge solutions empower healthcare professionals with unprecedented insights, enabling early detection and monitoring of neurological disorders such as Parkinson's disease. With a steadfast commitment to improving patient outcomes, we seamlessly integrate our AI-driven platform to revolutionize the landscape of neurology diagnostics and drug discovery. Backed by a dedicated team of experts and powered by state-of-the-art technology, Solvemed Limited remains steadfast in its mission to redefine the standards of neurological care worldwide.

sewts GmbH, founded in 2019 and located in Munich, Germany, specializes in automation technology focused on the processing of easily deformable materials, particularly textiles. The company collaborates with the Technical University of Munich to create finite element (FE) simulations that accurately replicate textile behavior. Its flagship product, Velum, is an AI-driven technology that analyzes textiles and converts insights into robotic commands. This innovative solution supports real-time motion and trajectory planning, enabling efficient control of industrial robots and coordination among multiple robots. sewts' technology streamlines complex manual processes in industrial settings, such as laundries and garment manufacturing, while promoting sustainability and innovation in production methods. The company is supported by several investors, including APEX Ventures and Bayern Kapital, which underscores its commitment to advancing the robotics and textile industries.

Upfront Diagnostics is a healthcare company focused on the development of innovative blood biomarkers aimed at enhancing medical diagnosis, particularly for stroke patients experiencing large vessel occlusions. By enabling rapid and precise identification of this stroke subtype, Upfront Diagnostics' biomarkers facilitate quicker treatment decisions by clinicians, paramedics, and nurses. This timely intervention is crucial for improving patient outcomes, as it can significantly reduce the time to treatment, thereby minimizing disabilities and fatalities associated with strokes. The company holds a portfolio of patents that safeguard its proprietary biomarkers, underscoring its commitment to advancing stroke care and improving overall healthcare efficiency.

Zetta Genomics is a company based in Cambridge, England, founded in 2018, that focuses on managing large-scale genomic data for precision medicine. It operates a user-centric platform that facilitates direct connections between individuals and researchers, allowing users to share their personal health and genomic data. This platform supports research into a range of common disorders, such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. Zetta Genomics enables individuals to participate in studies with the choice to opt in or out, ensuring they have transparency and control over their data. The company utilizes distributed database technology and adheres to strict security practices to maximize the benefits of genomic data while maintaining data privacy.

Planqc is a developer of advanced quantum computing technology that focuses on leveraging the unique properties of individual atoms to store and process information. By utilizing these atomic qubits, Planqc arranges them in highly scalable arrays and manipulates their states with precisely controlled laser pulses. This innovative approach allows the company to effectively scale its quantum systems to thousands of qubits, positioning itself as a leader in achieving industry-relevant quantum advantages. Through its cutting-edge technology, Planqc aims to facilitate the storage and processing of quantum information, paving the way for significant advancements in various sectors.

Refined Laser Systems is a specialized manufacturer of biophotonics devices, focusing on stain-free tissue diagnostics using its proprietary fiber-based tunable picosecond laser technology. The company's innovative laser systems enable rapid and reliable diagnoses, significantly reducing the time required compared to traditional methods.

OroraTech is a global intelligence-as-a-service company based in Munich, Germany, with additional operations in Canada and Brazil. Founded in 2018, the company specializes in leveraging thermal data to provide sustainable solutions for Earth. Their flagship product, Wildfire Solution, utilizes high-resolution thermal data from both proprietary and public space-based sensors to offer real-time situational awareness and prompt risk alerts for wildfires. This system detects fires of any scale, day or night, ensuring timely action. With a team of over 100 experts, OroraTech has established a comprehensive global monitoring network since 2022, delivering innovative solutions for environmental sustainability.

Solvemed Group is a neuroscience artificial intelligence company focused on transforming patient care and drug discovery in the realm of neurodegenerative diseases, particularly Parkinson's disease. The company utilizes proprietary machine learning technology to create innovative diagnostic and predictive digital biomarkers, which facilitate accurate, early, and cost-effective diagnosis and monitoring tools for patients and healthcare professionals. By addressing the unmet needs of neurological patients, Solvemed aims to provide reliable diagnostics that enhance treatment outcomes and improve overall quality of care. Moreover, the company's advancements in biomarker development support the creation of disease-modifying drugs, thereby optimizing clinical trial efficiency in collaboration with biopharmaceutical partners. The team at Solvemed comprises leading scientists and technology experts who collaborate with renowned research institutions globally, ensuring that their work is anchored in world-class science and contributes to improving healthcare systems while alleviating the financial burdens associated with inadequate diagnostics.

Lyfegen is a global provider of drug access, pricing, and rebate management services, with headquarters in Basel, Switzerland, and Boston, USA. The company offers a platform that assists healthcare payers, pharmaceutical companies, and medical technology providers in developing effective pricing agreements for medicines and streamlining the management of drug rebates. By leveraging advanced software, Lyfegen enables clients to collect, analyze, and reconcile diverse healthcare data, facilitating automation in value-based healthcare contracting. This approach aims to enhance access to treatments, improve patient health outcomes, and increase affordability in the healthcare sector.

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

OKAPI:Orbits is a software-as-a-service startup focused on enhancing the sustainability of space travel through its advanced Collision Avoidance Software designed for satellites. The company provides a comprehensive platform for online risk monitoring and collision avoidance, offering features such as environment visualization, maneuver design, conjunction analysis, re-entry predictions, and high-accuracy orbit propagation and determination. This suite of tools enables researchers and satellite operators to ensure secure satellite operations while facilitating seamless integration with ground segments, thereby contributing to the creation of a more sustainable space environment.

Senisca is a senotherapeutics company established in 2020, focused on developing anti-aging oligonucleotide therapeutics. The company aims to provide innovative pharmaceutical treatments for age-related chronic diseases by creating a new generation of oligonucleotide-based interventions. These therapeutics target the underlying mechanisms of aging, restoring the ability of cells to regulate gene expression effectively. By rejuvenating aged cells, Senisca seeks to improve healthspan and address both the diseases and aesthetic manifestations of aging, ultimately enabling individuals to live healthier for longer periods.

Elucidate GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing a financial crime risk management platform. The company's platform, Elucidate FinCrime Index (EFI), employs probabilistic modeling and machine learning to assess and manage financial crime risks for financial institutions. By providing ratings and data analysis, Elucidate helps businesses grow and promote lawful behavior, fostering a fairer and more transparent system. The platform enables seamless collaboration between front and back office teams, enhancing customer service and reducing risk through comprehensive data analysis and continuous monitoring of risk exposure.

Celeris Therapeutics is an AI-first drug discovery company that focuses on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address high unmet medical needs in diseases like Parkinson's and various cancers. The company has created the Celeris One platform, which utilizes structure-based geometric deep learning to enhance the design and development of degraders by prioritizing specific E3 ligases, designing effective linkers, and selecting optimal compounds for synthesis. Additionally, Celeris Therapeutics operates an in-house automated laboratory that facilitates rapid generation of experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to discover and develop small-molecule degrader therapies across multiple therapeutic areas, while also advancing its own internal drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.

Zetta Genomics is a company based in Cambridge, England, founded in 2018, that focuses on managing large-scale genomic data for precision medicine. It operates a user-centric platform that facilitates direct connections between individuals and researchers, allowing users to share their personal health and genomic data. This platform supports research into a range of common disorders, such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. Zetta Genomics enables individuals to participate in studies with the choice to opt in or out, ensuring they have transparency and control over their data. The company utilizes distributed database technology and adheres to strict security practices to maximize the benefits of genomic data while maintaining data privacy.

Morpher is a blockchain trading platform that aims to democratize trading by enabling users to trade various assets, including stocks, commodities, and currencies, without any fees and with infinite liquidity. Utilizing the Ethereum blockchain, Morpher replaces traditional intermediaries such as banks and brokers with its decentralized protocol. Users can stake the platform's native token on the price movements of different markets, allowing for a unique trading experience that includes the ability to short assets and trade with leverage. The platform operates 24/7, providing users with continuous access to markets, and is capable of creating new trading opportunities for assets not typically available through conventional channels.

Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the development of refrigeration solutions, particularly for cryogen-free cooling applications. The company focuses on providing easy-to-use, turn-key cryostats that facilitate low-temperature investigations of material samples, thereby accelerating the development and testing of quantum hardware and related electronics. Kiutra's innovative cooling platforms achieve continuous sub-Kelvin temperatures without relying on liquid cooling media, such as helium-3, which is both rare and costly. This technology is essential for enabling cryogenic conditions in a compact and cost-efficient manner, making it applicable for advanced fields like quantum computing, quantum communications, and quantum sensing. By offering efficient cooling solutions, Kiutra supports research and industry customers in their pursuit of scalable quantum technologies.

TriLite Technologies GmbH, based in Vienna, Austria, specializes in manufacturing and selling ultra-small RGB laser beam scanners. These innovative products are designed for use in Augmented Reality (AR), Mixed Reality (MR), and Virtual Reality (VR) head-mounted devices, head-up displays, pico projectors, and smart home applications. TriLite's solutions leverage advanced machine learning algorithms and proprietary software, enabling the creation of compact, high-quality projection displays. The company's software-first approach ensures optimal image quality and user experience for its Original Equipment Manufacturer (OEM) customers.

Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.

Mobius Labs GmbH is a Berlin-based company founded in 2018 that specializes in developing advanced image and video understanding software. The company offers lightweight computer vision algorithms that can be licensed for integration with various applications, devices, and processes. Its flagship product, Superhuman Vision, utilizes few-shot learning models that allow for easy customization, enabling even non-experts to create new models. These models can operate locally on edge devices with limited processing power and storage, making them both cost-effective and scalable. Mobius Labs aims to enhance visual searches by transforming images and videos into actionable insights, thereby providing businesses with the ability to generate automatic metadata and seize new market opportunities.

Celeris Therapeutics is an AI-first drug discovery company that focuses on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address high unmet medical needs in diseases like Parkinson's and various cancers. The company has created the Celeris One platform, which utilizes structure-based geometric deep learning to enhance the design and development of degraders by prioritizing specific E3 ligases, designing effective linkers, and selecting optimal compounds for synthesis. Additionally, Celeris Therapeutics operates an in-house automated laboratory that facilitates rapid generation of experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to discover and develop small-molecule degrader therapies across multiple therapeutic areas, while also advancing its own internal drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.

VividQ Limited is a technology company based in Cambridge, United Kingdom, specializing in the development of software frameworks for generating, compressing, and transmitting 3D holographic images and video. The company offers a variety of products, including VividQ Capture, an API for converting 3D data into holographic formats, and VividQ Squeeze, a solution for compressing point cloud 3D data. Additionally, VividQ Core enables multi-user interactions with holograms at different focal planes, while VividQ View allows integration of various spatial light modulators into its holographic architecture. VividQ's advanced computational display technology aims to revolutionize digital displays by integrating holographic visuals into consumer electronics, augmented reality, virtual reality, and automotive applications. The company, which was formerly known as Penteract28 Limited before rebranding in 2017, collaborates with leading original equipment manufacturers to enhance user experiences in various sectors, including gaming, immersive simulations, and depth sensing.

Yuri is a company specializing in the design and manufacturing of hardware for the aviation and aerospace industry. It offers a comprehensive range of services aimed at supporting microgravity research and experiments. These services encompass mission definition, hardware selection and development, as well as launch and return logistics. In addition to its focus on space missions, Yuri is involved in various scientific research areas, including growing cell cultures in 3D, modeling human diseases, analyzing proteins and molecules, synthetic biology, studying plant biology, and nanofluidics. This diverse expertise positions Yuri as a key player in advancing research capabilities within the aerospace sector.

OroraTech is a global intelligence-as-a-service company based in Munich, Germany, with additional operations in Canada and Brazil. Founded in 2018, the company specializes in leveraging thermal data to provide sustainable solutions for Earth. Their flagship product, Wildfire Solution, utilizes high-resolution thermal data from both proprietary and public space-based sensors to offer real-time situational awareness and prompt risk alerts for wildfires. This system detects fires of any scale, day or night, ensuring timely action. With a team of over 100 experts, OroraTech has established a comprehensive global monitoring network since 2022, delivering innovative solutions for environmental sustainability.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced laser-powered photonic integrated circuits that aim to revolutionize display technology. The company manufactures liquid-crystal display (LCD) backlights utilizing glass-based waveguides to control and transport visible light with precision. Its innovative quantum light chip serves as a high-performance light source, delivering exceptional brightness and color quality for 3D, virtual reality, and augmented reality applications while consuming significantly less energy than traditional technologies. By replacing standard backlight units with its proprietary circuits, VitreaLab enhances LCD performance in energy efficiency, brightness, contrast ratio, and color rendering, enabling superior laser displays and immersive 3D imagery without the need for goggles.

Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.

sewts GmbH, founded in 2019 and located in Munich, Germany, specializes in automation technology focused on the processing of easily deformable materials, particularly textiles. The company collaborates with the Technical University of Munich to create finite element (FE) simulations that accurately replicate textile behavior. Its flagship product, Velum, is an AI-driven technology that analyzes textiles and converts insights into robotic commands. This innovative solution supports real-time motion and trajectory planning, enabling efficient control of industrial robots and coordination among multiple robots. sewts' technology streamlines complex manual processes in industrial settings, such as laundries and garment manufacturing, while promoting sustainability and innovation in production methods. The company is supported by several investors, including APEX Ventures and Bayern Kapital, which underscores its commitment to advancing the robotics and textile industries.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Elucidate GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing a financial crime risk management platform. The company's platform, Elucidate FinCrime Index (EFI), employs probabilistic modeling and machine learning to assess and manage financial crime risks for financial institutions. By providing ratings and data analysis, Elucidate helps businesses grow and promote lawful behavior, fostering a fairer and more transparent system. The platform enables seamless collaboration between front and back office teams, enhancing customer service and reducing risk through comprehensive data analysis and continuous monitoring of risk exposure.

Phantasma Labs Limited is a London-based company founded in 2018 that specializes in developing a simulation platform aimed at enhancing the training of autonomous vehicles. The company focuses on creating crucial data sets and models of human behavior to improve the understanding of self-driving cars in various scenarios, particularly in extreme situations. By immersing real humans in virtual environments, Phantasma Labs enables artificial intelligence systems to learn from realistic interactions with pedestrians, cyclists, and other road users. This innovative approach facilitates the generation of large-scale data sets that simulate real-life conditions, allowing clients to benefit from advanced decision support without the need for extensive big data. Through its technology, Phantasma Labs contributes to safer and more effective autonomous vehicle operations by training AI to navigate complex human behaviors.

Morpher is a blockchain trading platform that aims to democratize trading by enabling users to trade various assets, including stocks, commodities, and currencies, without any fees and with infinite liquidity. Utilizing the Ethereum blockchain, Morpher replaces traditional intermediaries such as banks and brokers with its decentralized protocol. Users can stake the platform's native token on the price movements of different markets, allowing for a unique trading experience that includes the ability to short assets and trade with leverage. The platform operates 24/7, providing users with continuous access to markets, and is capable of creating new trading opportunities for assets not typically available through conventional channels.

Novoic Ltd is a digital biotech company based in London, United Kingdom, founded in 2019. It specializes in developing a speech analytics platform that aids clinicians in identifying and monitoring changes in speech patterns associated with neurological diseases, particularly in the early detection of dementia. The company's platform, known as Sforza, incorporates advanced AI algorithms and utilizes proprietary datasets to decode complex speech alterations. Additionally, it includes tools such as Surfboard and BlaBla, which are Python libraries designed for audio and language feature extraction, respectively. Novoic's innovative approach combines cutting-edge machine learning research with practical applications in speech therapy, enhancing diagnostic capabilities for brain diseases.

Quibim, headquartered in Valencia, Spain, is a leader in whole-body medical imaging analysis, focusing on the integration of artificial intelligence in image processing. The company provides advanced solutions for extracting quantitative information from radiological images, which aids in the diagnosis of high-incidence illnesses and evaluates the effects of pharmacological treatments. Quibim Precision®, its comprehensive imaging ecosystem, is utilized by pharmaceutical companies and research teams worldwide for a variety of applications, including disease detection and monitoring treatment efficacy. By leveraging AI technology, Quibim enhances the ability to detect pathologies across all body parts and imaging modalities, ultimately contributing to improved health outcomes.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Elucidate GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing a financial crime risk management platform. The company's platform, Elucidate FinCrime Index (EFI), employs probabilistic modeling and machine learning to assess and manage financial crime risks for financial institutions. By providing ratings and data analysis, Elucidate helps businesses grow and promote lawful behavior, fostering a fairer and more transparent system. The platform enables seamless collaboration between front and back office teams, enhancing customer service and reducing risk through comprehensive data analysis and continuous monitoring of risk exposure.

TriLite Technologies GmbH, based in Vienna, Austria, specializes in manufacturing and selling ultra-small RGB laser beam scanners. These innovative products are designed for use in Augmented Reality (AR), Mixed Reality (MR), and Virtual Reality (VR) head-mounted devices, head-up displays, pico projectors, and smart home applications. TriLite's solutions leverage advanced machine learning algorithms and proprietary software, enabling the creation of compact, high-quality projection displays. The company's software-first approach ensures optimal image quality and user experience for its Original Equipment Manufacturer (OEM) customers.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced laser-powered photonic integrated circuits that aim to revolutionize display technology. The company manufactures liquid-crystal display (LCD) backlights utilizing glass-based waveguides to control and transport visible light with precision. Its innovative quantum light chip serves as a high-performance light source, delivering exceptional brightness and color quality for 3D, virtual reality, and augmented reality applications while consuming significantly less energy than traditional technologies. By replacing standard backlight units with its proprietary circuits, VitreaLab enhances LCD performance in energy efficiency, brightness, contrast ratio, and color rendering, enabling superior laser displays and immersive 3D imagery without the need for goggles.

MindPeak GmbH is a technology company based in Hamburg, Germany, founded in 2018. It specializes in developing artificial intelligence software tools aimed at enhancing the accuracy and efficiency of cancer diagnostics. The company's flagship product, BreastAI, is designed for the quantification of breast cancer immunohistochemistry (IHC) and can be integrated into third-party software systems. MindPeak's solutions automate tissue diagnostics, enabling pathologists to identify and quantify tumorous regions and detect breast cancer cells more effectively. By streamlining tasks such as cell and biomarker quantification, MindPeak's tools allow cancer specialists to focus on critical decision-making in clinical environments, ultimately improving patient care while making diagnostic processes more accessible and cost-effective.

Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the development of refrigeration solutions, particularly for cryogen-free cooling applications. The company focuses on providing easy-to-use, turn-key cryostats that facilitate low-temperature investigations of material samples, thereby accelerating the development and testing of quantum hardware and related electronics. Kiutra's innovative cooling platforms achieve continuous sub-Kelvin temperatures without relying on liquid cooling media, such as helium-3, which is both rare and costly. This technology is essential for enabling cryogenic conditions in a compact and cost-efficient manner, making it applicable for advanced fields like quantum computing, quantum communications, and quantum sensing. By offering efficient cooling solutions, Kiutra supports research and industry customers in their pursuit of scalable quantum technologies.

Avinew, Inc. develops artificial intelligence and telematics-based software solutions specifically for the insurance industry. Founded in 2016 and headquartered in Westlake Village, California, the company focuses on providing auto insurance services tailored for autonomous and semi-autonomous vehicles. Avinew's offerings include usage-based insurance programs that leverage driving data, artificial intelligence, and machine learning to assess premium discount eligibility. By utilizing these advanced technologies, Avinew aims to enhance road safety while delivering value to vehicle drivers and fleet operators. The company was previously known as DRIAV, Inc. and rebranded to Avinew, Inc. in January 2019.

T3K-Forensics GmbH, founded in 2007 and based in Vienna, Austria, specializes in mobile forensics software and services tailored for law enforcement agencies. The company develops advanced software solutions, including its LEAP product, which analyzes smartphone data and generates comprehensive reports on the content of the devices. T3K-Forensics is committed to enhancing mobile security and provides customized analytics solutions to forensic law enforcement units. In addition to its software offerings, the company also delivers training programs in areas such as mobile phone extraction and analysis, smartphone forensics, and SQLite forensics for smartphones, ensuring that law enforcement professionals are well-equipped to handle mobile data investigations.

Lendflo is a peer-to-peer invoice financing marketplace that utilizes blockchain technology and machine learning to provide small and medium-sized businesses with an efficient and cost-effective financing solution. Founded in 2017 and based in London, the platform aims to simplify the invoice financing process, enabling businesses to access funds more quickly and easily. As of May 2020, Lendflo operates as a subsidiary of ABH Holdings S.A., enhancing its capabilities within the financial technology sector.

ImageBiopsy Lab is a leading developer of AI-based software for image analysis in musculoskeletal (MSK) radiology, orthopedic surgery, and traumatology. The company has created an advanced platform that automates the reading and prioritization of low-risk, low-reimbursement plain film MSK X-rays, thereby optimizing physician resources and minimizing manual reporting. ImageBiopsy Lab aims to address all clinically relevant MSK and orthopedic use cases, extending its capabilities from basic X-rays to more complex MRI and CT scans. To enhance its technology, the company collaborates with prominent medical institutions across the US and Europe, facilitating access to extensive training data and expert annotations. With offices in both regions, ImageBiopsy Lab is advancing its suite of AI modules, which are currently undergoing FDA and CE certification processes, to cover a wide array of common MSK-X-ray applications. The platform is designed to improve the early detection of musculoskeletal diseases, ultimately enabling patients to receive more precisely targeted and affordable therapies.

Mobius Labs GmbH is a Berlin-based company founded in 2018 that specializes in developing advanced image and video understanding software. The company offers lightweight computer vision algorithms that can be licensed for integration with various applications, devices, and processes. Its flagship product, Superhuman Vision, utilizes few-shot learning models that allow for easy customization, enabling even non-experts to create new models. These models can operate locally on edge devices with limited processing power and storage, making them both cost-effective and scalable. Mobius Labs aims to enhance visual searches by transforming images and videos into actionable insights, thereby providing businesses with the ability to generate automatic metadata and seize new market opportunities.

Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.

HAAWK, Inc. is a media services company based in Studio City, California, that focuses on managing and monetizing the copyrights of independent music, film, and television catalogs. Founded in 2017, the company specializes in rights management, copyright enforcement, and digital music distribution, with a particular emphasis on platforms like YouTube, Facebook, and Instagram. HAAWK provides a copyright management platform that enables clients to administer, distribute, and license their content effectively. The platform also monitors user-generated content to detect unauthorized uploads, allowing copyright holders to monetize these instances through advertisements. In addition, HAAWK offers micro-sync licensing services to further support its clients in monetizing their creative works.

Kivu Technologies, established in Austria in 2016, is a multidisciplinary team of engineers, developers, data scientists, analysts, and security professionals dedicated to harnessing innovation for societal betterment. The company specializes in creating advanced network analytical platforms that utilize artificial intelligence and machine learning to enhance data intelligence within the security industry. By transforming complex data into visual networks, Kivu enables clients to address urgent security challenges effectively and efficiently. Their technology is particularly focused on combating issues such as terrorism, providing crucial real-time analytical services that support informed decision-making and enhance human security in an increasingly interconnected world.